Volumetric PET images were collected for 19 different neurotransmitter receptors and transporters across multiple studies. To protect patient confidentiality, individual participant maps were averaged within studies before being shared. Details of each study, the associated receptor/transporter, tracer, number of healthy participants, age and reference with full methodological details can be found in Table
1. A more extensive table can be found in the supplementary material (Supplementary Table
3), which additionally includes the PET camera, number of males and females, PET modeling method, reference region, scan length, modeling notes and additional references, if applicable. In all cases, only healthy participants were scanned (
n = 1,238; 718 males and 520 females). Images were acquired using best practice imaging protocols recommended for each radioligand
56 . Altogether, the images are an estimate proportional to receptor densities, and we, therefore, refer to the measured value (that is, binding potential and tracer distribution volume) simply as density. Note that the NMDA receptor tracer ([
18F]GE-179) binds to open (that is, active) NMDA receptors
86 (link),95 (link). PET images were all registered to the MNI-ICBM 152 non-linear 2009 (version c, asymmetric) template and then parcellated to 100, 200 and 400 regions according to the Schaefer atlas
12 (link). Receptors and transporters with more than one mean image of the same tracer (that is, 5-HT
1B, D
2, mGluR
5 and VAChT) were combined using a weighted average after confirming that the images are highly correlated to one another (Supplementary Fig.
13a). Finally, each tracer map corresponding to each receptor/transporter was z-scored across regions and concatenated into a final region by receptor matrix of relative densities.
In some cases, more than one tracer map was available for the same neurotransmitter receptor/transporter. We show the comparisons between tracers in Supplementary Fig.
13b for the following neurotransmitter receptors/transporters: 5-HT1
A9 (link),69 (link), 5-HT1
B9 (link),69 (link),70 (link), 5-HT2
A9 (link),69 (link),96 (link), 5-HTT
9 (link),69 (link), CB
1 (refs. (
89 (link),97 (link))), D
2 (refs. (
59 (link),60 (link),98 (link),99 (link))), DAT
64 (link),100 (link), GABA
A8 (link),64 (link), MOR
93 (link),101 (link) and NET
65 (link),102 (link). Here, we make some specific notes: (1) 5-HTT and GABA
A involve comparisons between the same tracers (DASB and flumazenil, respectively), but one map is converted to density using autoradiography data (see ref.
9 (link) and ref.
8 (link)) and the other is not
7 ,64 (link),69 (link); (2) raclopride is a popular D
2 tracer but has unreliable binding in the cortex and is, therefore, an inappropriate tracer to use for mapping D
2 densities in the cortex, but we show its comparison to FLB457 and another D
2 tracer, fallypride, for completeness
98 (link),99 (link),103 ; and (3) the chosen carfentanil (MOR) map was collated across carfentanil images in the PET Turku Centre database—because our alternative map is a partly overlapping subset of participants, we did not combine the tracers into a single mean map
93 (link),101 (link).
Synapse density in the cortex was measured in 76 healthy adults (45 males, 48.9 ± 18.4 years of age) by administering [
11C]UCB-J, a PET tracer that binds to the synaptic vesicle glycoprotein 2A (SV2A)
104 (link). Data were collected on an HRRT PET camera for 90 minutes after injection. Non-displaceable binding potential (BP
ND) was modeled using SRTM2, with the centrum semiovale as reference and
fixed to 0.027 (population value). This group-averaged map was first presented in ref.
105 (link).
Hansen J.Y., Shafiei G., Markello R.D., Smart K., Cox S.M., Nørgaard M., Beliveau V., Wu Y., Gallezot J.D., Aumont É., Servaes S., Scala S.G., DuBois J.M., Wainstein G., Bezgin G., Funck T., Schmitz T.W., Spreng R.N., Galovic M., Koepp M.J., Duncan J.S., Coles J.P., Fryer T.D., Aigbirhio F.I., McGinnity C.J., Hammers A., Soucy J.P., Baillet S., Guimond S., Hietala J., Bedard M.A., Leyton M., Kobayashi E., Rosa-Neto P., Ganz M., Knudsen G.M., Palomero-Gallagher N., Shine J.M., Carson R.E., Tuominen L., Dagher A, & Misic B. (2022). Mapping neurotransmitter systems to the structural and functional organization of the human neocortex. Nature Neuroscience, 25(11), 1569-1581.